Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

Kidney International

Volumn 76, Issue 1, 2009, Pages 63-71

  Lu, Ting Chi ^a,b   Wang, Zhao Hui ^c   Feng, Xiaobei ^c   Chuang, Peter Y ^a   Fang, Wei ^a   Shen, Yuhong ^d   Levy, David E ^e   Xiong, Huabao ^a   Chen, Nan ^c   He, John Cijiang ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d ROCKEFELLER UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Collagen IV; Diabetic nephropathy; Glomerulosclerosis; Mesangial cells; Stat3

Indexed keywords

ALBUMIN; COLLAGEN TYPE 4; CREATININE; DRUG VEHICLE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DISEASE MARKER; EARLY DIAGNOSIS; GENE MUTATION; GLOMERULUS FILTRATION; INFLAMMATION; KNOCKOUT GENE; MACROPHAGE ACTIVATION; MESANGIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; STAT3 GENE; STREPTOZOCIN DIABETES;

EID: 67449161568     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.98     Document Type: Article

References (43)

1. US Renal Data System, USRDS 2005 Annual Data Report. Atlas of End stage Renal Disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease: Bethesda, MD 2005.
2. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004; 25: 971-1010.
3. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-1634.
4. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines In diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442.
5. Ng DP, Nurbaya S, Ye SH et al. An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. Kidney lnt 2008; 74: 521-527.
6. Berthier CC, Zhang H, Schin M et al. Enhanced expression of JAK-STAT pathway members in human diabetic nephropathy. Diabetes 2009; 58: 469-477.
7. Marrero MB, Banes-Bercell AK, Stern DM et al. Role of the JAK/STAT signaling pathway In diabetic nephropathy. Am J Physiol Renal Physiol 2006; 290: F762-F768.
8. Simon AR, Rai U, Fanburg BL ef al. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998; 275: C1640-C1652.
9. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000; 19: 2607-2611.
10. Stehouwer CD, Gall MA, Twisk JW et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002; 51: 1157-1165.
11. Saraheimo M, Teppo AM, Forsblom C et al. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia 2003; 46: 1402-1407.
12. Shikano M, Sobajima H, Yoshikawa H et al. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 2000; 85: 81-85.
13. Takeda K, Noguchi K, Shi W et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sei USA 1997; 94: 3801-3804.
14. Wen Z, Zhong Z, Darnell Jr JE. Maximal activation of transcription by Stat 1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241-250.
15. Shen Y, Schlessinger K, Zhu X et al. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 2004; 24: 407-419.
16. Takeda K, Clausen BE, Kaisho T et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10: 39-49.
17. Wang X, Shaw S, Amirl F et al. Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells. Diabetes 2002; 51: 3505-3509.
18. Sugimoto H, Shikata K, Hirata K et al. Increased expression of intercellular adhesion molecule-1 (ICAM-I) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-I upregulation. Diabetes 1997; 46: 2075-2081.
19. Yu Z, Kone BC. The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and iuducible nitric oxide synthase transrepression in mesangial cells. J Am Soc Nephrol 2004; 15: 585-591.
20. Yoshida Y, Kumar A, Koyama Y et al. Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 2004; 279: 1768-1776.
21. Zong CS, Chan J, Levy DE et al. Mechanism of STAT3 activation by Insulinlike growth factor I receptor. J Biol Chem 2000; 275: 15099-15105.
22. Oemar BS, Foellmer HG, Hodgdon-Anandant L et al. Regulation of insulin-like growth factor I receptors in diabetic mesangial cells. J Biol Chem 1991;266:2369-2373.
23. Chen NY, Chen WY, Bellush L et al. Effects of streptozotocln treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 1995; 136:660-667.
24. Huang JS, Guh JY, Chen HC et al. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway In AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001; 81: 102-113.
25. Banes AK, Shaw S, Jenkins J et al. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins In diabetic rat kidney glomeruli. Am J Physiol Renal Physiol 2004; 286: F653-F659.
26. Amiri F, Shaw S, Wang X et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney lnt 2002; 61: 1605-1616.
27. Huang JS, Chuang LY, Guh JY et al. Antioxidants attenuate high glucoseinduced hypertrophic growth in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 293: F1072-F1082.
28. Li R, Yang N, Zhang L et al. Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome. Am J Nephrol 2007; 27: 580-589.
29. Banes-Berceli AK, Shaw S, Ma G et al. Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. Am J Physiol Renal Physiol 2006; 291: F116-F121.
30. Takahashi T, Abe H, Arai H ef al. Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 2005; 280: 7100-7106.
31. Yanagita M, Arai H, Nakano T et al. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J Biol Chem 2001; 276: 42364-42369.
32. He JC, Husain M, Sunamoto M et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPKI ,2 pathways. J Clin Invest 2004; 114: 643-651.
33. Jung JE, Lee HG, Cho IH et al. STAT3 is a potential modulator of HIF-1medlated VEGF expression In human renal carcinoma cells. FASEB J 2005; 19: 1296-1298.
34. Nechemia-Arbely Y, Barkan D, Pizov G et al. IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 2008; 19: 1106-1115.
35. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury In streptozotocin-treated mice. Kidney lnt 2006; 69: 73-80.
36. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. JAm Soc Nephrol 2005; 16: 1711-1722.
37. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003.
38. Mezzano S, Aros C, Droguett A et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19: 2505-2512.
39. Bierhaus A, Schiekofer S, Schwaninger M et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50: 2792-2808.
40. He C, Zalups RK, Henderson DA et al. Molecular analysis of spontaneous glomerulosclerosis In Os/+ mice, a model with reduced nephron mass. Am J Physiol 1995; 269: F266-F273.
41. Zheng F, Zeng YJ, Plati AR et al. Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6db/ db mice. Kidney lnt 2006; 70: 507-514.
42. Takemoto M, Asker N, Gerhardt H et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 2002; 161: 799-805.
43. Ql Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 2004; 286: F590-F596.